Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Federico

Showing results (61-70 of 271) with videos related to

Pageof 28
Sort By:
Hematological Oncology|April 30, 2014
Dismal outcome of T-cell lymphoma patients failing first-line treatment: results of a population-based study from the Modena Cancer RegistryIrene Biasoli, Marina Cesaretti, Monica Bellei, et al.
Hemasphere|April 21, 2021
EHA/ESMO Clinical Practice Guidelines for the Management of Malignant Lymphoma: Recommendations for the Second Phase of the COVID-19 PandemicMartin Dreyling, Igor Aurer, Massimo Federico, et al.
Hemasphere|November 2, 2020
Double Hit Lymphoma Diagnosis and Treatment in Europe-A Cross-Sectional Survey of Clinical Practice by the EHA Lymphoma Working Party (EHA LyG)Igor Aurer, Martin Dreyling, Massimo Federico, et al.
European Journal of Radiology|October 23, 2012
MRI before initial surgery outside of clinical trials: the real world!Laura Cortesi, Elisabetta De Matteis, Claudia Cirilli, et al.
Hematological Oncology|February 4, 2017
Combination of rituximab and nonpegylated liposomal doxorubicin (R-NPLD) as front-line therapy for aggressive non-Hodgkin lymphoma (NHL) in patients 80 years of age or older: a single-center retrospective studyGiuseppina Ricciuti, Erica Finolezzi, Stefania Luciani, et al.
Haematologica|August 28, 2015
Precision medicine in diffuse large B-cell lymphoma: hitting the targetJoost S Vermaat, Steven T Pals, Anas Younes, et al.
Annals of Epidemiology|April 28, 2015
Cancer incidence, mortality, and survival in Eastern Libya: updated report from the Benghazi Cancer RegistryMufid El Mistiri, Massimiliano Salati, Luigi Marcheselli, et al.
European Journal of Human Genetics : EJHG|April 4, 2003
Italian family with two independent mutations: 3358T/A in BRCA1 and 8756delA in BRCA2 genesLaura Cortesi, Daniela Turchetti, Chiara Bertoni, et al.
Hematological Oncology|January 25, 2012
Tumour burden predicts treatment resistance in patients with early unfavourable or advanced stage Hodgkin lymphoma treated with ABVD and radiotherapyPaolo G Gobbi, Emilio Bassi, Manuela Bergonzi, et al.
British Journal of Haematology|June 5, 2003
Prevalence and prognostic significance of sMUC-1 levels in plasma cell dyscrasiasStefano Luminari, Maria Goldaniga, Fulvia Ceccherelli, et al.
Pageof 28

Showing results (61-70 of 271) with videos related to

Sort By:
Pageof 28
Hematological Oncology|April 30, 2014
Dismal outcome of T-cell lymphoma patients failing first-line treatment: results of a population-based study from the Modena Cancer RegistryIrene Biasoli, Marina Cesaretti, Monica Bellei, et al.
Hemasphere|April 21, 2021
EHA/ESMO Clinical Practice Guidelines for the Management of Malignant Lymphoma: Recommendations for the Second Phase of the COVID-19 PandemicMartin Dreyling, Igor Aurer, Massimo Federico, et al.
Hemasphere|November 2, 2020
Double Hit Lymphoma Diagnosis and Treatment in Europe-A Cross-Sectional Survey of Clinical Practice by the EHA Lymphoma Working Party (EHA LyG)Igor Aurer, Martin Dreyling, Massimo Federico, et al.
European Journal of Radiology|October 23, 2012
MRI before initial surgery outside of clinical trials: the real world!Laura Cortesi, Elisabetta De Matteis, Claudia Cirilli, et al.
Hematological Oncology|February 4, 2017
Combination of rituximab and nonpegylated liposomal doxorubicin (R-NPLD) as front-line therapy for aggressive non-Hodgkin lymphoma (NHL) in patients 80 years of age or older: a single-center retrospective studyGiuseppina Ricciuti, Erica Finolezzi, Stefania Luciani, et al.
Haematologica|August 28, 2015
Precision medicine in diffuse large B-cell lymphoma: hitting the targetJoost S Vermaat, Steven T Pals, Anas Younes, et al.
Annals of Epidemiology|April 28, 2015
Cancer incidence, mortality, and survival in Eastern Libya: updated report from the Benghazi Cancer RegistryMufid El Mistiri, Massimiliano Salati, Luigi Marcheselli, et al.
European Journal of Human Genetics : EJHG|April 4, 2003
Italian family with two independent mutations: 3358T/A in BRCA1 and 8756delA in BRCA2 genesLaura Cortesi, Daniela Turchetti, Chiara Bertoni, et al.
Hematological Oncology|January 25, 2012
Tumour burden predicts treatment resistance in patients with early unfavourable or advanced stage Hodgkin lymphoma treated with ABVD and radiotherapyPaolo G Gobbi, Emilio Bassi, Manuela Bergonzi, et al.
British Journal of Haematology|June 5, 2003
Prevalence and prognostic significance of sMUC-1 levels in plasma cell dyscrasiasStefano Luminari, Maria Goldaniga, Fulvia Ceccherelli, et al.
Pageof 28